[HTML][HTML] The use of long-acting injectable antipsychotics in schizophrenia: evaluating the evidence

CU Correll, L Citrome, PM Haddad… - The Journal of clinical …, 2016 - psychiatrist.com
METHODS A group of 8 experts on the management of schizophrenia and LAIs met to
evaluate the evidence and to develop a set of recommendations regarding the clinical use …

Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies

PM Haddad, C Brain, J Scott - Patient related outcome measures, 2014 - Taylor & Francis
Nonadherence with medication occurs in all chronic medical disorders. It is a particular
challenge in schizophrenia due to the illness's association with social isolation, stigma, and …

Schizophrenia stigma in mental health professionals and associated factors: A systematic review

KM Valery, A Prouteau - Psychiatry research, 2020 - Elsevier
Background: The consequences of schizophrenia stigma are numerous and highly
damaging to individuals, their families, the health care system and society. Mental health …

The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal

S Brissos, MR Veguilla, D Taylor… - Therapeutic …, 2014 - journals.sagepub.com
Despite their widespread use, long-acting injectable (LAI) antipsychotics (APs) are often
regarded with some negativity because of the assumption of punishment, control and …

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

TRE Barnes… - Journal of …, 2011 - journals.sagepub.com
These guidelines from the British Association for Psychopharmacology address the scope
and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving …

Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia

G Kaplan, J Casoy, J Zummo - Patient preference and adherence, 2013 - Taylor & Francis
Schizophrenia is a debilitating chronic disease that requires lifelong medical care and
supervision. Even with treatment, the majority of patients relapse within 5 years, and suicide …

Comparison of long-acting injectable antipsychotics with oral antipsychotics and suicide and all-cause mortality in patients with newly diagnosed schizophrenia

CY Huang, SC Fang, YHJ Shao - JAMA network open, 2021 - jamanetwork.com
Importance Schizophrenia is generally considered to be among the most severe psychiatric
disorders because of the excessive mortality associated with it. Research to find means to …

Econometric model of non-performing loans determinants

N Radivojević, D Cvijanović, D Sekulic… - Physica A: Statistical …, 2019 - Elsevier
The paper presents the use of the difference GMM and the system GMM for the purpose of
determining the critical determinants of non-performing loans. The aim of the paper is to …

Efficacy of long‐acting injectable versus oral antipsychotic drugs in early psychosis: A systematic review and meta‐analysis

L Lian, DD Kim, RM Procyshyn… - Early intervention in …, 2022 - Wiley Online Library
Aim Long‐acting injectable antipsychotic drugs (LAIs) are often used as an alternative to
oral antipsychotics (OAPs) in individuals with psychosis who demonstrate poor medication …

[图书][B] Recovery and mental health: A critical sociological account

D Pilgrim, A McCranie - 2013 - books.google.com
For most of us, the term'recovery'in mental health implies hope and normality for those
suffering from emotional distress. It is understandable why recovery has therefore become a …